University Of Texas Bio Path Holdings Inc Transaction History

University Of Texas

  • $504 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 10, 2020
SELL
$6.97 - $12.3 $133,510 - $235,606
-19,155 Closed
0 $0
Q2 2019

Aug 19, 2019
BUY
$12.52 - $20.81 $12 - $20
1 Added 0.01%
19,155 $256,000
Q1 2019

May 01, 2019
BUY
$1.81 - $38.86 $34,668 - $744,324
19,154 New
19,154 $391,000

About BIO-PATH HOLDINGS INC

BPTH Quotes by TradingView
  • Ticker BPTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,160,160
  • Market Cap $6.37M
  • Description
  • Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...
More about BPTH
Track This Portfolio

Track University Of Texas Portfolio

Follow University Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of University Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on University Of Texas with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email